This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Neisseria meningitidis induces pathology-associated cellular and molecular changes in 1
trigeminal Schwann cells 2
Running title: N. meningitidis induces Schwann cell pathology 3
Ali Delbaza,b,c, Mo Chena,b,c, Freda E.-C. Jend, Benjamin L. Schulze, Alain-4
Dominique Gorsef, Michael P. Jenningsd, James A. St Johna,b,c*, Jenny A. K. Ekberga,b,c*#, 5
6 aClem Jones Centre for Neurobiology and Stem Cell Research, Griffith University, Brisbane, 7
4111, QLD, Australia; 8
bGriffith Institute for Drug Discovery, Griffith University, Brisbane, 4111, QLD, Australia; 9
cMenzies Health Institute Queensland, Griffith University, Southport, 4222, QLD, Australia; 10
dInstitute for Glycomics, Griffith University, Southport, 4222, QLD, Australia 11
eAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular 12
Biosciences, the University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia 13
fQFAB Bioinformatics, Institute for Molecular Bioscience, The University of Queensland, St. 14
1. Dando SJ, Mackay-Sim A, Norton R, Currie BJ, St John JA, Ekberg JA, Batzloff M, Ulett GC, 497 Beacham IR. 2014. Pathogens penetrating the central nervous system: infection pathways 498 and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev 27:691-726. 499
2. Nazareth L, Lineburg KE, Chuah MI, Tello Velasquez J, Chehrehasa F, St John JA, Ekberg JA. 500 2015. Olfactory ensheathing cells are the main phagocytic cells that remove axon debris 501 during early development of the olfactory system. J Comp Neurol 523:479-94. 502
3. Brooks R, Woods CW, Benjamin DK, Jr., Rosenstein NE. 2006. Increased case-fatality rate 503 associated with outbreaks of Neisseria meningitidis infection, compared with sporadic 504 meningococcal disease, in the United States, 1994-2002. Clin Infect Dis 43:49-54. 505
4. Christensen H, May M, Bowen L, Hickman M, Trotter CL. 2010. Meningococcal carriage by 506 age: a systematic review and meta-analysis. Lancet Infect Dis 10:853-61. 507
5. Coureuil M, Jamet A, Bille E, Lecuyer H, Bourdoulous S, Nassif X. 2019. Molecular 508 interactions between Neisseria meningitidis and its human host. Cell Microbiol 509 doi:10.1111/cmi.13063:e13063. 510
6. Bille E, Zahar JR, Perrin A, Morelle S, Kriz P, Jolley KA, Maiden MC, Dervin C, Nassif X, Tinsley 511 CR. 2005. A chromosomally integrated bacteriophage in invasive meningococci. J Exp Med 512 201:1905-13. 513
7. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, 514 Caugant DA, Feavers IM, Achtman M, Spratt BG. 1998. Multilocus sequence typing: a 515 portable approach to the identification of clones within populations of pathogenic 516 microorganisms. Proc Natl Acad Sci U S A 95:3140-5. 517
8. Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D. 518 2009. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic 519 review and meta-analysis. Lancet Infect Dis 9:31-44. 520
9. van Sorge NM, Doran KS. 2012. Defense at the border: the blood–brain barrier versus 521 bacterial foreigners. Future microbiology 7:383-394. 522
10. Nassif X, Bourdoulous S, Eugene E, Couraud PO. 2002. How do extracellular pathogens cross 523 the blood-brain barrier? Trends Microbiol 10:227-32. 524
11. Quagliarello V, Scheld WM. 1992. Bacterial meningitis: pathogenesis, pathophysiology, and 525 progress. N Engl J Med 327:864-72. 526
12. Carbonnelle E, Hill DJ, Morand P, Griffiths NJ, Bourdoulous S, Murillo I, Nassif X, Virji M. 527 2009. Meningococcal interactions with the host. Vaccine 27 Suppl 2:B78-89. 528
13. Virji M. 2009. Pathogenic neisseriae: surface modulation, pathogenesis and infection 529 control. Nat Rev Microbiol 7:274-86. 530
14. Simonis A, Schubert-Unkmeir A. 2016. Interactions of meningococcal virulence factors with 531 endothelial cells at the human blood-cerebrospinal fluid barrier and their role in 532 pathogenicity. FEBS Lett 590:3854-3867. 533
15. Coureuil M, Bourdoulous S, Marullo S, Nassif X. 2014. Invasive meningococcal disease: a 534 disease of the endothelial cells. Trends Mol Med 20:571-8. 535
16. Coureuil M, Join-Lambert O, Lecuyer H, Bourdoulous S, Marullo S, Nassif X. 2012. Mechanism 536 of meningeal invasion by Neisseria meningitidis. Virulence 3:164-72. 537
17. Nikulin J, Panzner U, Frosch M, Schubert-Unkmeir A. 2006. Intracellular survival and 538 replication of Neisseria meningitidis in human brain microvascular endothelial cells. Int J 539 Med Microbiol 296:553-8. 540
18. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. 2001. Meningococcal 541 disease. N Engl J Med 344:1378-88. 542
19. Stephens DS, Greenwood B, Brandtzaeg P. 2007. Epidemic meningitis, meningococcaemia, 543 and Neisseria meningitidis. Lancet 369:2196-2210. 544
20. Sjölinder H, Jonsson A-B. 2010. Olfactory Nerve—A Novel Invasion Route of Neisseria 545 meningitidis to Reach the Meninges. PLoS ONE 5:e14034. 546
21. St John J, Walkden H, Nazareth L, Beagley K, Ulett G, R. Batzloff M, Beacham I, Ekberg J. 547 2016. Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the 548 Trigeminal Nerve after Intranasal Inoculation, vol 84. 549
22. Dons L, Jin Y, Kristensson K, Rottenberg ME. 2007. Axonal transport of Listeria 550 monocytogenes and nerve-cell-induced bacterial killing. J Neurosci Res 85:2529-37. 551
24. Panni P, Ferguson IA, Beacham I, Mackay-Sim A, Ekberg JA, St John JA. 2013. Phagocytosis of 554 bacteria by olfactory ensheathing cells and Schwann cells. Neurosci Lett 539:65-70. 555
25. Neal JW, Gasque P. 2016. The role of primary infection of Schwann cells in the aetiology of 556 infective inflammatory neuropathies. J Infect 73:402-418. 557
26. Windus LC, Claxton C, Allen CL, Key B, St John JA. 2007. Motile membrane protrusions 558 regulate cell-cell adhesion and migration of olfactory ensheathing glia. Glia 55:1708-19. 559
27. Tello Velasquez J, Nazareth L, Quinn RJ, Ekberg JA, St John JA. 2016. Stimulating the 560 proliferation, migration and lamellipodia of Schwann cells using low-dose curcumin. 561 Neuroscience 324:140-50. 562
28. Duval K, Grover H, Han LH, Mou Y, Pegoraro AF, Fredberg J, Chen Z. 2017. Modeling 563 Physiological Events in 2D vs. 3D Cell Culture. Physiology (Bethesda) 32:266-277. 564
29. Ko KR, Frampton JP. 2016. Developments in 3D neural cell culture models: the future of 565 neurotherapeutics testing? Expert Rev Neurother 16:739-41. 566
30. D'Aiuto L, Naciri J, Radio N, Tekur S, Clayton D, Apodaca G, Di Maio R, Zhi Y, Dimitrion P, 567 Piazza P, Demers M, Wood J, Chu C, Callio J, McClain L, Yolken R, McNulty J, Kinchington P, 568 Bloom D, Nimgaonkar V. 2018. Generation of three-dimensional human neuronal cultures: 569 application to modeling CNS viral infections. Stem Cell Res Ther 9:134. 570
31. Chen M, Shah MP, Shelper TB, Nazareth L, Barker M, Tello Velasquez J, Ekberg JAK, Vial M-L, 571 St John JA. 2019. Naked Liquid Marbles: A Robust Three-Dimensional Low-Volume Cell-572 Culturing System. ACS Applied Materials & Interfaces doi:10.1021/acsami.8b22036. 573
32. Hopkins AM, DeSimone E, Chwalek K, Kaplan DL. 2015. 3D in vitro modeling of the central 574 nervous system. Prog Neurobiol 125:1-25. 575
33. Watson PMD, Kavanagh E, Allenby G, Vassey M. 2017. Bioengineered 3D Glial Cell Culture 576 Systems and Applications for Neurodegeneration and Neuroinflammation. SLAS Discov 577 22:583-601. 578
34. Urbańska K, Sokołowska J, Szmidt M, Sysa P. 2014. Glioblastoma multiforme – an overview. 579 Contemporary Oncology 18:307-312. 580
35. Winger MJ, Macdonald DR, Cairncross JG. 1989. Supratentorial anaplastic gliomas in adults. 581 The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 582 71:487-93. 583
36. Arcot R, Ramakrishnan K, Rao S. 2012. Peripheral and cranial nerve sheath tumors-a clinical 584 spectrum. Indian J Surg 74:371-5. 585
37. Baderca F, Cojocaru S, Lazar E, Lazureanu C, Faur A, Lighezan R, Alexa A, Raica M, Valean M, 586 Balica N. 2008. Schwannoma of the lip: case report and review of the literature. Rom J 587 Morphol Embryol 49:391-8. 588
38. Chandra S, Jerva MJ, Clemis JD. 1975. Ultrastructural characteristics of human neurilemoma 589 cell nuclei. Cancer Res 35:2000-6. 590
39. Chebib I, Hornicek FJ, Nielsen GP, Deshpande V. 2015. Cytomorphologic features that 591 distinguish schwannoma from other low-grade spindle cell lesions. Cancer Cytopathol 592 123:171-9. 593
40. Kim BH, Cho WS, Han BS. 2011. Spontaneous multicentric malignant schwannoma in a male 594 Fischer 344 rat. Toxicol Res 27:149-52. 595
41. Shaktawat SS, Golka D. 2007. Floret-like multinucleated giant cells in neurofibroma. Diagn 596 Pathol 2:47. 597
42. Taungjaruwinai WM, Goldberg LJ. 2009. Multinucleate giant cells in neurofibromas: a clue to 598 the diagnosis of neurofibromatosis. J Cutan Pathol 36:1164-7. 599
43. Brodbeck WG, Anderson JM. 2009. Giant cell formation and function. Curr Opin Hematol 600 16:53-7. 601
44. McNally AK, Anderson JM. 2011. Macrophage fusion and multinucleated giant cells of 602 inflammation. Adv Exp Med Biol 713:97-111. 603
45. Fujita M, Mizuno M, Nagasaka T, Wakabayashi T, Maeda K, Ishii D, Arima T, Kawajiri A, 604 Inagaki M, Yoshida J. 2004. Aurora-B dysfunction of multinucleated giant cells in glioma 605 detected by site-specific phosphorylated antibodies. J Neurosurg 101:1012-7. 606
46. Marquet G, Dameron O, Saikali S, Mosser J, Burgun A. 2007. Grading glioma tumors using 607 OWL-DL and NCI Thesaurus. AMIA Annu Symp Proc:508-12. 608
47. Walker C, Baborie A, Crooks D, Wilkins S, Jenkinson MD. 2011. Biology, genetics and imaging 609 of glial cell tumours. Br J Radiol 84 Spec No 2:S90-106. 610
48. Temme A, Geiger KD, Wiedemuth R, Conseur K, Pietsch T, Felsberg J, Reifenberger G, 611 Tatsuka M, Hagel C, Westphal M, Berger H, Simon M, Weller M, Schackert G. 2010. Giant cell 612 glioblastoma is associated with altered aurora b expression and concomitant p53 mutation. J 613 Neuropathol Exp Neurol 69:632-42. 614
49. Elwell C, Mirrashidi K, Engel J. 2016. Chlamydia cell biology and pathogenesis. Nat Rev 615 Microbiol 14:385-400. 616
50. Benanti EL, Nguyen CM, Welch MD. 2015. Virulent Burkholderia species mimic host actin 617 polymerases to drive actin-based motility. Cell 161:348-60. 618
51. Stevens JM, Ulrich RL, Taylor LA, Wood MW, Deshazer D, Stevens MP, Galyov EE. 2005. 619 Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can 620 functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei 621 bimA mutant. J Bacteriol 187:7857-62. 622
52. Tamura A. 2016. Tuberculosis and Lung Cancer. Kekkaku 91:17-25. 623 53. Vento S, Lanzafame M. 2011. Tuberculosis and cancer: a complex and dangerous liaison. 624
Lancet Oncol 12:520-2. 625 54. Chaturvedi AK, Gaydos CA, Agreda P, Holden JP, Chatterjee N, Goedert JJ, Caporaso NE, 626
Engels EA. 2010. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol 627 Biomarkers Prev 19:1498-505. 628
55. Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, Song Y. 2011. Chlamydia pneumoniae 629 infection and lung cancer risk: a meta-analysis. Eur J Cancer 47:742-7. 630
56. Josefson D. 2001. Chlamydia increases risk of cervical cancer, vol 322. 631 57. Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ, Wurscher M, 632
Johnson LG, Galloway DA, Daling JR. 2007. Risk of cervical cancer associated with Chlamydia 633 trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120:650-5. 634
58. Wittenmayer N, Jandrig B, Rothkegel M, Schlüter K, Arnold W, Haensch W, Scherneck S, 635 Jockusch BM. 2004. Tumor Suppressor Activity of Profilin Requires a Functional Actin Binding 636 Site. Molecular Biology of the Cell 15:1600-1608. 637
59. Tonnetti L, Netzel-Arnett S, Darnell GA, Hayes T, Buzza MS, Anglin IE, Suhrbier A, Antalis TM. 638 2008. SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell 639 survival. Cancer research 68:5648-5657. 640
60. Gao Y, Chen Y, Xu D, Wang J, Yu G. 2014. Differential expression of ANXA1 in benign human 641 gastrointestinal tissues and cancers. BMC Cancer 14:520-520. 642
61. Slanina H, Hebling S, Hauck CR, Schubert-Unkmeir A. 2012. Cell Invasion by Neisseria 643 meningitidis Requires a Functional Interplay between the Focal Adhesion Kinase, Src and 644 Cortactin. PLoS ONE 7:e39613. 645
62. Galmiche A, Sauzay C, Chevet E, Pluquet O. 2017. Role of the unfolded protein response in 646 tumor cell characteristics and cancer outcome. Curr Opin Oncol 29:41-47. 647
63. Rozpędek W, Pytel D, Mucha B, Leszczyńska H, Diehl JA, Majsterek I. 2016. The Role of the 648 PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic 649 Reticulum Stress. Current molecular medicine 16:533-544. 650
64. Johswich KO, Gray-Owen SD. 2019. Modeling Neisseria meningitidis Infection in Mice: 651 Methods and Logistical Considerations for Nasal Colonization and Invasive Disease. Methods 652 Mol Biol 1969:149-168. 653
65. Mackinnon FG, Gorringe AR, Funnell SG, Robinson A. 1992. Intranasal infection of infant 654 mice with Neisseria meningitidis. Microb Pathog 12:415-20. 655
66. Chauhan VS, Sterka DG, Jr., Gray DL, Bost KL, Marriott I. 2008. Neurogenic exacerbation of 656 microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J 657 Immunol 180:8241-9. 658
67. Jen FE, Warren MJ, Schulz BL, Power PM, Swords WE, Weiser JN, Apicella MA, Edwards JL, 659 Jennings MP. 2013. Dual pili post-translational modifications synergize to mediate 660 meningococcal adherence to platelet activating factor receptor on human airway cells. PLoS 661 Pathog 9:e1003377. 662
68. Srikhanta YN, Dowideit SJ, Edwards JL, Falsetta ML, Wu HJ, Harrison OB, Fox KL, Seib KL, 663 Maguire TL, Wang AH, Maiden MC, Grimmond SM, Apicella MA, Jennings MP. 2009. 664 Phasevarions mediate random switching of gene expression in pathogenic Neisseria. PLoS 665 Pathog 5:e1000400. 666
69. Chen M, Shah M, Shelper T, Nazareth L, Barker M, Tello Velasquez J, Ekberg JA, Vial ML, St 667 John JA. 2019. Naked liquid marbles: a robust three-dimensional low-volume cell culturing 668 system. ACS Applied Materials & Interfaces. 669
70. Peak IR, Chen A, Jen FEC, Jennings C, Schulz BL, Saunders NJ, Khan A, Seifert HS, Jennings 670 MP. 2016. Neisseria meningitidis lacking the major porins PorA and PorB are viable and 671 modulate apoptosis and the oxidative burst of neutrophils. Journal of proteome research 672 15:2356-2365. 673
71. Zacchi LF, Schulz BL. 2016. SWATH-MS Glycoproteomics Reveals Consequences of Defects in 674 the Glycosylation Machinery. Mol Cell Proteomics 15:2435-47. 675
72. Kerr ED, Phung TK, Caboche CH, Fox GP, Platz GJ, Schulz BL. 2019. The intrinsic and regulated 676 proteomes of barley seeds in response to fungal infection. Anal Biochem 580:30-35. 677
73. Choi M, Chang CY, Clough T, Broudy D, Killeen T, MacLean B, Vitek O. 2014. MSstats: an R 678 package for statistical analysis of quantitative mass spectrometry-based proteomic 679 experiments. Bioinformatics 30:2524-6. 680
74. Godlewski J, Krichevsky AM, Johnson MD, Chiocca EA, Bronisz A. 2015. Belonging to a 681 network—microRNAs, extracellular vesicles, and the glioblastoma microenvironment. 682 Neuro-Oncology 17:652-662. 683
75. MacDonald BT, Tamai K, He X. 2009. Wnt/β-catenin signaling: components, mechanisms, 684 and diseases. Developmental cell 17:9-26. 685
76. Kim N-G, Koh E, Chen X, Gumbiner BM. 2011. E-cadherin mediates contact inhibition of 686 proliferation through Hippo signaling-pathway components. Proceedings of the National 687 Academy of Sciences of the United States of America 108:11930-11935. 688
77. Sagheer U, Gong J, Chung C. 2015. Pigment Epithelium-Derived Factor (PEDF) is a 689 Determinant of Stem Cell Fate: Lessons from an Ultra-Rare Disease. J Dev Biol 3:112-128. 690
78. Hou J, Ge C, Cui M, Liu T, Liu X, Tian H, Zhao F, Chen T, Cui Y, Yao M, Li J, Li H. 2017. Pigment 691 epithelium-derived factor promotes tumor metastasis through an interaction with laminin 692 receptor in hepatocellular carcinomas. Cell Death Dis 8:e2969. 693
79. de Haas CJ. 1999. New insights into the role of serum amyloid P component, a novel 694 lipopolysaccharide-binding protein. FEMS Immunol Med Microbiol 26:197-202. 695
80. Skinner M, Cohen AS. 1988. Amyloid P component. Methods Enzymol 163:523-36. 696 81. Levo Y, Wollner S, Treves AJ. 1986. Serum amyloid P-component levels in patients with 697